1. Fajans SS, Vinik AI: Diagnosis and treatment of insulinoma. In Diagnosis and Management of Endocrine Related Tumors. Fanten RJ, Manni A, Eds. Boston, Martinus Nijhoff, 1984, p. 235

2. Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV: Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 353:249-254, 2005

3. Edis AJ, McIlrath DC, van Heerden JA, Fulton RE, Sheedy PF, Service FJ, Dale AJ: Insulinoma--current diagnosis and surgical management. Curr Probl Surg 13:1-45, 1976

4. Friesen SR: Treatment of the Zollinger-Ellison syndrome. A 25 year assessment. Am J Surg 143:331-338, 1982

5. Thompson NW, Eckhauser FE: Malignant islet-cell tumors of the pancreas. World J Surg 8:940-951, 1984

6. Thompson, NW. The surgical treatment of islet cell tumors of the pancreas. 1981. New York, Grune & Stratton.

7. Glaser B, Shapiro B, Glowniak J, Fajans SS, Vinik AI: Effects of secretin on the normal and pathological beta-cell. J Clin Endocrinol Metab 66:1138-1143, 1988

8. Starke A, Saddig C, Kirch B, Tschahargane C, Goretzki P: Islet hyperplasia in adults: challenge to preoperatively diagnose non-insulinoma pancreatogenic hypoglycemia syndrome. World J Surg 30:670-679, 2006

9. Anlauf M, Wieben D, Perren A, Sipos B, Komminoth P, Raffel A, Kruse ML, Fottner C, Knoefel WT, Monig H, Heitz PU, Kloppel G: Persistent hyperinsulinemic hypoglycemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence, and characterization of beta-cell changes. Am J Surg Pathol 29:524-533, 2005

10. Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S, Calin GA, Volinia S, Liu CG, Scarpa A, Croce CM: MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24:4677-4684, 2006

11. Vinik A: Endocrine tumors of the gastroenteropancreatic axis. In Diagnosis and Management of Endocrine-Related Tumors305, 1984

12. Vinik, AI,Strodel,WE,Cho,K,Eckhauser,FE,andThompson,N.Localizationofhormonallyactivegastrointestinaltumors. 1983. Grune&Stratton.

13. GlowniakJV,ShapiroB,VinikAI,GlaserB,ThompsonNW,ChoKJ:Percutaneoustranshepaticvenoussamplingofgastrin:valueinsporadicandfamilialislet-celltumorsandG-cellhyperfunction. NEnglJMed307:293-297,1982

14. KaplanEL,LeeCH:Recentadvancesinthediagnosisandtreatmentofinsulinomas. SurgClinNorthAm59:119-129,1979

15. LeQuesneLP,NabarroJD,KurtzA,ZweigS:Themanagementofinsulintumoursofthepancreas. BrJSurg66:373-378,1979

16. ModlinIM:Endocrinetumorsofthepancreas. SurgGynecolObstet149:751-769,1979

17. StefaniniP,CarboniM,PatrassiN,BasoliA:Beta-isletcelltumorsofthepancreas:resultsofastudyon1,067cases. Surgery75:597-609,1974

18. Robins JM, Bookstein JJ, Oberman HA, Fajans SS: Selective angiography in localizing islet-cell tumors of the pancreas. A further appraisal. Radiology 106:525-528, 1973

19. Gibril F, Reynolds JC, Doppman JL, Chen CC, Venzon DJ, Termanini B, Weber HC, Stewart CA, Jensen RT: Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study. Ann Intern Med 125:26-34, 1996

20. Doppman JL, Miller DL, Chang R, Shawker TH, Gorden P, Norton JA: Insulinomas: localization with selective intraarterial injection of calcium. Radiology 178:237-241, 1991

21. Cho KJ, Vinik AI, Thompson NW, Shields JJ, Porter DJ, Brady TM, Cadavid G, Fajans SS: Localization of the source of hyperinsulinism: percutaneous transhepatic portal and pancreatic vein catheterization with hormone assay. Am J Roentgenol 139:237-245, 1982

22. Ingemansson S, Kuhl C, Larsson LI, Lunderquist A, Lundquist I: Localization of insulinomas and islet cell hyperplasias by pancreatic vein catheterization and insulin assay. Surg Gynecol Obstet 146:724-734, 1978

23. Katz LB, Aufses AH, Jr. , Rayfield E, Mitty H: Preoperative localization and intraoperative glucose monitoring in the management of patients with pancreatic insulinoma. Surg Gynecol Obstet 163:509-512, 1986

24. Vinik AI, Thompson N: Controversies in the management of Zollinger-Ellison syndrome. Ann Intern Med 105:956-959, 1986

25. Wild D, Macke H, Christ E, Gloor B, Reubi JC: Glucagon-like peptide 1-receptor scans to localize occult insulinomas. N Engl J Med 359:766-768, 2008

26. McAuley G, Delaney H, Colville J, Lyburn I, Worsley D, Govender P, Torreggiani WC: Multimodality preoperative imaging of pancreatic insulinomas. Clin Radiol 60:1039-1050, 2005

27. Hardy OT, Hernandez-Pampaloni M, Saffer JR, Scheuermann JS, Ernst LM, Freifelder R, Zhuang H, MacMullen C, Becker S, Adzick NS, Divgi C, Alavi A, Stanley CA: Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism. J Clin Endocrinol Metab 92:4706-4711, 2007

28. Kauhanen S, Seppanen M, Minn H, Gullichsen R, Salonen A, Alanen K, Parkkola R, Solin O, Bergman J, Sane T, Salmi J, Valimaki M, Nuutila P: Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients. J Clin Endocrinol Metab 92:1237-1244, 2007

29. Pasieka JL, McLeod MK, Thompson NW, Burney RE: Surgical approach to insulinomas. Assessing the need for preoperative localization. Arch Surg 127:442-447, 1992

30. Ravi K, Britton BJ: Surgical approach to insulinomas: are pre-operative localisation tests necessary? Ann R Coll Surg Engl 89:212-217, 2007

31. Nikfarjam M, Warshaw AL, Axelrod L, Deshpande V, Thayer SP, Ferrone CR, Fernandez-del CC: Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital. Ann Surg 247:165-172, 2008

32. Tseng LM, Chen JY, Won JG, Tseng HS, Yang AH, Wang SE, Lee CH: The role of intra-arterial calcium stimulation test with hepatic venous sampling (IACS) in the management of occult insulinomas. Ann Surg Oncol 14:2121-2127, 2007

33. Grover AC, Skarulis M, Alexander HR, Pingpank JF, Javor ED, Chang R, Shawker T, Gorden P, Cochran C, Libutti SK: A prospective evaluation of laparoscopic exploration with intraoperative ultrasound as a technique for localizing sporadic insulinomas. Surgery 138:1003-1008, 2005

34. Sweet MP, Izumisato Y, Way LW, Clark OH, Masharani U, Duh QY: Laparoscopic enucleation of insulinomas. Arch Surg 142:1202-1204, 2007

35. Fajans SS, Floyd JC, Jr. , Knopf RF, Rull J, Guntsche EM, Conn JW: Benzothiadiazine suppression of insulin release from normal and abnormal islet tissue in man. J Clin Invest 45:481-492, 1966

36. Fajans SS, Floyd JC, Jr. , Thiffault CA, Knopf RF, Harrison TS, Conn JW: Further studies on diazoxide suppression of insulin release from abnormal and normal islet tissue in man. Ann N Y Acad Sci 150:261-280, 1968

37. Ulbrecht JS, Schmeltz R, Aarons JH, Greene DA: Insulinoma in a 94-year-old woman: long-term therapy with verapamil. Diabetes Care 9:186-188, 1986

38. Blum I, Doron M, Laron Z, Atsmon A, Tiqva P: Prevention of hypoglycemic attacks by propranolol in a patient suffering from insulinoma. Diabetes 24:535-537, 1975

39. Schusdziarra V, Zyznar E, Rouiller D, Boden G, Brown JC, Arimura A, Unger RH: Splanchnic somatostatin: a hormonal regulator of nutrient homeostasis. Science 207:530-532, 1980

40. Brodows RG, Campbell RG: Control of refractory fasting hypoglycemia in a patient with suspected insulinoma with diphenylhydantoin. J Clin Endocrinol Metab 38:159-162, 1974

41. Hofeldt FD, Dippe SE, Levin SR, Karam JH, Blum MR, Forsham PH: Effects of diphenylhydantoin upon glucose-induced insulin secretion in three patients with insulinoma. Diabetes 23:192-198, 1974

42. Tsai ST, Eckhauser FE, Thompson NW, Strodel WE, Vinik AI: Perioperative use of long-acting somatostatin analog (SMS 201-995) in patients with endocrine tumors of the gastroenteropancreatic axis. Surgery 100:788-795, 1986

43. Osei K, O'Dorisio TM: Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones. Ann Intern Med 103:223-225, 1985

44. Portela-Gomes GM, Stridsberg M, Grimelius L, Rorstad O, Janson ET: Differential expression of the five somatostatin receptor subtypes in human benign and malignant insulinomas - predominance of receptor subtype 4. Endocr Pathol 18:79-85, 2007

45. Alabraba EB, Taniere P, Reynolds GM, Stewart PM, Wigmore SJ, Bramhall SR: Expression and functional consequences of oestrogen and progesterone receptors in human insulinomas. Endocr Relat Cancer 14:1081-1088, 2007